Krishna Institute of Medical Sciences Ltd (KIMS) is currently trading at 824.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Krishna Institute of Medical Sciences Limited operates an integrated multi‑specialty hospital network delivering tertiary and quaternary care across Telangana, Andhra Pradesh, Maharashtra, Karnataka and Kerala, focusing on complex specialities such as cardiac sciences, organ transplantation, neurosciences and oncology under the KIMS Hospitals brand. Q3 FY26 marked a record consolidated quarter with total revenue crossing INR 1,003 crore, driven by higher ARPOB and new hospital contributions, but profitability compressed: EBITDA margin fell to 20.4% and PAT declined materially year‑on‑year due to start‑up losses, higher finance cost and depreciation from recent expansions. KIMS has been pursuing rapid network growth, commissioning seven hospitals in 2025 and disclosing an overall bed capacity target north of 9,100 beds; management expects most current expansion capex to be complete with FY27 capex of about INR 500–600 crore and subsequent moderation in incremental debt. Clinical and technology differentiation is evident with multi‑robotic platforms, Tulsa‑Pro and MRgFUS installations and a dominant transplant program; coupled with doctor equity partnerships and O&M models, KIMS Hospitals is leveraging both advanced technology and human capital to bulk up referral volumes and premium case mix.

Over the past 52 weeks, Krishna Institute of Medical Sciences Ltd has traded between a low of ₹575.55 and a high of ₹858.15. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Krishna Institute of Medical Sciences Ltd has a market capitalization of approximately 34,453.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Krishna Institute of Medical Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 142.72 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 34,453.13 Cr, Krishna Institute of Medical Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Krishna Institute of Medical Sciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Krishna Institute of Medical Sciences Ltd is 142.72. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

KIMS reported consolidated revenue from operations of ₹11,795 million for the quarter ended June 30, 2026, up 35% year-on-year.

KIMS reported consolidated revenue from operations of Rs 1,075 crore in Q4 FY26, up 34.8% year-on-year and 7.7% quarter-on-quarter.

KIMS allotted 19,867,549 equity shares to eligible qualified institutional buyers on June 19, 2026.

Krishna Institute of Medical Sciences closed its QIP on June 19, 2026, after opening the issue on June 16, 2026.